BACOBA - BAP5191 - First in human trial on cutaneous leishmaniasis

 The aim of this translational research project is to conduct a first in human (clinical phase I) study and test BAP5191, a new formulation intended to be a cure for cutaneous leishmaniasis – a neglected stigmatizing and debilitating tropical disease with an estimated 600 000 to 1 million of new...

Ongoing
01.05.2021 - 30.04.2023
Clinical Trial
Innosuisse - Swiss Innovation Agency / Innovation project with implementation partners
Clinical Operations, Clinical Statistics and Data Management
Elisabeth Reus , Sonja Bernhard